November 25, 2019 Deadline: Kaskela Law LLC Announces Investor Class Action Lawsuit Against electroCore, Inc. (ECOR) & Encour...
Kaskela Law LLC announces that an investor class action lawsuit
has been filed against electroCore, Inc. (“electroCore” or the
“Company”) (NASDAQ: ECOR) on behalf of certain investors.
electroCore investors who purchased shares of the Company’s
stock between June 21, 2018 and May 14, 2019 are encouraged
to contact Kaskela Law LLC at (888) 715–1740, or online at
http://kaskelalaw.com/case/electrocore-inc/, for additional
information about this action and their legal rights and
electroCore is a commercial-stage bioelectronic medicine company
focused on non-invasive vagus nerve stimulation (“VNS”) therapy.
The Company is developing gammaCore, a prescription-only
non-invasive VNS therapy for the acute treatment of pain associated
with migraine and episodic cluster headache in adults.
On or about June 21, 2018, electroCore completed its initial
public offering (“IPO”) of common stock, selling 5.2 million shares
of stock to investors at $15.00 per share.
On May 14, 2019, the Company announced first quarter 2019
financial and operational results, which included a quarterly
operating loss of $14.2 million. Following this news, shares of
electroCore’s stock declined nearly 30% in value, to close on May
15, 2019 at $3.75 per share.
Then, on September 25, 2019, the Company disclosed that the U.S.
Food and Drug Administration (“FDA”) “has requested more
information and analysis of the clinical data included in the
Company’s premarket notification, or ‘510(k)’ submission, seeking
an expanded indication for the use of gammaCore.” On this news,
shares of electroCore’s stock fell an additional 23% in value, to
close on September 25, 2019 at $2.57 per share.
electroCore investors may, no later than November 25, 2019,
seek to be appointed as a lead plaintiff of the investor class.
Investors are encouraged to contact Kaskela Law LLC prior to the
deadline to receive additional information about this action.
Kaskela Law LLC exclusively represents investors in securities
fraud and shareholder rights litigation in state and federal
actions. For additional information about Kaskela Law LLC please
version on businesswire.com: https://www.businesswire.com/news/home/20191125005528/en/
KASKELA LAW LLC 18 Campus Blvd., Suite 100 Newtown
Square, PA 19073 (484) 258 – 1585 (888) 715 – 1740
www.kaskelalaw.com Attn: D. Seamus Kaskela, Esq.
Historical Stock Chart
From Dec 2020 to Jan 2021
Historical Stock Chart
From Jan 2020 to Jan 2021